<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> is the most common form of <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Amyloid-beta protein is considered as a key factor of pathogenesis of <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>l-3-n-butylphthalide (L-NBP), an anti-<z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> drug, has been shown to have therapeutic effects in vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> animal models </plain></SENT>
<SENT sid="3" pm="."><plain>In the present study, we investigated the potential of L-NBP to protect against <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo>, oxidative damage and neuropathological changes induced by intracerebroventricular infusion of amyloid-beta <z:chebi fb="7" ids="16670">peptide</z:chebi> in rats </plain></SENT>
<SENT sid="4" pm="."><plain>Daily treatments of 10 and 30 mg/kg L-NBP significantly improved spatial learning deficits and attenuated working <z:e sem="disease" ids="C0233794" disease_type="Mental or Behavioral Dysfunction" abbrv="">memory deficits</z:e> in <z:mp ids='MP_0001465'>Morris water maze</z:mp> task </plain></SENT>
<SENT sid="5" pm="."><plain>L-NBP partially reversed the reduction of <z:chebi fb="0" ids="16856">glutathione</z:chebi> peroxidase activities and decreased malondialdehyde levels in the cortex and hippocampus </plain></SENT>
<SENT sid="6" pm="."><plain>Furthermore, L-NBP markedly inhibited amyloid-beta-induced neuronal <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, possibly by blocking caspase-3 activation </plain></SENT>
<SENT sid="7" pm="."><plain>In addition, L-NBP reduced activation of <z:chebi fb="15" ids="28087">glycogen</z:chebi> synthase kinase-3beta and tau protein phosphorylation </plain></SENT>
<SENT sid="8" pm="."><plain>Our results demonstrate that L-NBP protects against amyloid-beta-induced <z:hpo ids='HP_0002180'>neurodegeneration</z:hpo> and <z:hpo ids='HP_0001268'>cognitive decline</z:hpo> in a rat model, suggesting that it may have potential as a therapy for <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> </plain></SENT>
</text></document>